Jean GekasM.D.

Gekas J, Boomer TH, Rodrigue MA, Jinnett KN, Bhatt S

Use of cell-free signals as biomarkers for early and easy prediction of preeclampsia

Front Med (Lausanne), 10 , 2023.

Résumé | Liens:

Dubois ML, Winters PD, Rodrigue MA, Gekas J

Patient attitudes and preferences about expanded noninvasive prenatal testing

Front Genet, 14 , 2023.

Résumé | Liens:

Mossfield T, Soster E, Menezes M, Agenbag G, Dubois ML, Gekas J, Hardy T, Jurkowska M, Kleinfinger P, Loggenberg K, Marchili P, Sirica R,

Multisite assessment of the impact of cell-free DNA-based screening for rare autosomal aneuploidies on pregnancy management and outcomes

Front Genet, 13 , 2022.

Résumé | Liens:

Lapointe J, Dorval M, Chiquette J, Joly Y, Guertin JR, Laberge M, Gekas J, Hébert J, Pomey MP, Cruz-Marino T, Touhami O, Blanchet Saint-Pierre A, Gagnon S, Bouchard K, Rhéaume J, Boisvert K, Brousseau C, Castonguay L, Fortier S, Gosselin I, Lachapelle P, Lavoie S, Poirier B, Renaud MC, Ruizmangas MG, Sebastianelli A, Roy S, Côté M, Racine MM, Roy MC, Côté N, Brisson C, Charette N, Faucher V, Leblanc J, Dubeau MÈ, Plante M, Desbiens C, Beaumont M, Simard J, Nabi H

A Collaborative Model to Implement Flexible, Accessible and Efficient Oncogenetic Services for Hereditary Breast and Ovarian Cancer: The C-MOnGene Study

Cancers (Basel), 13 (11), 2021.

Résumé | Liens:

Rousseau F, Langlois S, Johnson JA, Gekas J, Bujold E, Audibert F, Walker M, Giroux S, Caron A, Clement V, Blais J, MacLeod T, Moore R, Gauthier J, Jouan L, Laporte A, Diallo O, Parker J, Swanson L, Zhao Y, Labelle Y, Giguere Y, Forest JC, Little J, Karsan A, Rouleau G

Prospective head-to-head comparison of accuracy of two sequencing platforms for screening for fetal aneuploidy by cell-free DNA: the PEGASUS study

Eur J Hum Genet, 27 (11), 2019.

Résumé | Liens:

Nshimyumukiza L, Beaumont JA, Duplantie J, Langlois S, Little J, Audibert F, McCabe C, Gekas J, Giguere Y, Gagne C, Reinharz D, Rousseau F

Cell-Free DNA-Based Non-invasive Prenatal Screening for Common Aneuploidies in a Canadian Province: A Cost-Effectiveness Analysis

J Obstet Gynaecol Can, 40 (1), 2018.

Résumé | Liens:

Mason-Suares H, Toledo D, Gekas J, Lafferty KA, Meeks N, Pacheco MC, Sharpe D, Mullen TE, Lebo MS

Juvenile myelomonocytic leukemia-associated variants are associated with neo-natal lethal Noonan syndrome

Eur J Hum Genet, 25 (4), 2017.

Résumé | Liens:

Langlois S, Johnson J, Audibert F, Gekas J, Forest JC, Caron A, Harrington K, Pastuck M, Meddour H, Tétu A, Little J, Rousseau F

Comparison of first-tier cell-free DNA screening for common aneuploidies with conventional publically funded screening

Prenat Diagn, 37 (12), 2017.

Résumé | Liens:

Gekas J, Langlois S, Ravitsky V, Audibert F, van den Berg DG, Haidar H, Rousseau F

Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues

Appl Clin Genet, 9 , 2016.

Résumé | Liens:

Ayub S, Gadji M, Krabchi K, Cote S, Gekas J, Maranda B, Drouin R

Three new cases of terminal deletion of the long arm of chromosome 7 and literature review to correlate genotype and phenotype manifestations

Am J Med Genet A, 170A (4), 2016.

Résumé | Liens: